Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bruce Booth currently holds 6,068 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce Booth has been a net seller of KYMR stock. They have purchased $36.6M and sold $141.3M worth of shares.
Bruce Booth's most recent insider trade was on Jun 24, 2026, when they sold 6,068 shares at $0.00 per share.
Bruce Booth serves as Executive at Kymera Therapeutics, Inc. (KYMR). They have executed 174 insider transactions totaling $177.9M over their tenure at the company.
Bruce Booth holds the position of Executive at Kymera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Bruce Booth has shown a selling trading pattern, with $36.6M in total purchases and $141.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bruce Booth was on Dec 10, 2025, when they sold $8.0M worth of KYMR shares. This transaction involved 85,862 shares at $93.20 per share.
Bruce Booth currently owns 6,068 shares of Kymera Therapeutics, Inc. (KYMR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bruce Booth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bruce Booth has 174 Form 4 filings on record as an insider at Kymera Therapeutics, Inc..
Set alerts for Bruce Booth and 40,000+ other insiders.